PerkinElmer Q3 Revenues Increase 3 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer's third quarter revenues increased 3 percent year over year, the firm reported after the close of the market on Wednesday.

For the three months ended Sept. 29, total revenues rose to $524.3 million from $509.6 million a year ago. Analysts, on average, expected revenues of $523.8 million.

On an organic basis, revenues rose 2 percent year over year, PerkinElmer Chairman and CEO Robert Friel said on a conference call following the release of the results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.